{"disease":{"id":"beh-et-s-syndrome-bs","name":"beh et s syndrome bs"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07073261","title":"Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":970,"lead_sponsor_name":"University of Cagliari","has_results":false},{"nct_id":"NCT07244614","title":"Ustekinumab in BEhçet's Syndrome STudy","phase":"","overall_status":"RECRUITING","enrollment_count":208,"lead_sponsor_name":"Groupe français d'étude des Maladies Inflammatoires de loeil","has_results":false},{"nct_id":"NCT06723106","title":"Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)","phase":"PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":144,"lead_sponsor_name":"Chugai Pharmaceutical","has_results":false},{"nct_id":"NCT06371417","title":"Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"Chugai Pharmaceutical","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}